Status:

COMPLETED

Managing Insulin Pumps for Exercise - Study 1

Lead Sponsor:

Buckinghamshire Healthcare NHS Trust

Collaborating Sponsors:

Animas Corporation

Conditions:

Type 1 Diabetes Mellitus

Eligibility:

All Genders

18-65 years

Brief Summary

People with Type 1 Diabetes Mellitus (T1DM) like to take part in sport and exercise, but problems with metabolism and blood glucose control can make this difficult. Some people with T1DM administer th...

Detailed Description

For the first part of the study, participants will be either people with type 1 diabetes treated with insulin pump therapy or volunteers without diabetes. The 2 groups will be matched as far as possib...

Eligibility Criteria

Inclusion

  • For participants with Type 1 Diabetes Mellitus
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged between 18 and 65 years
  • Diagnosed with Type 1 diabetes mellitus
  • Treated with CSII for at least 3 months
  • Exercises regularly for more than 1 hour per week
  • For participants without Type 1 Diabetes Mellitus
  • Participant is willing and able to give informed consent for participation in the study
  • Male or female, aged between 18 and 65 years
  • Exercises regularly for more than 1 hour per week

Exclusion

  • For participants with type 1 Diabetes Mellitus
  • People with any one of the following complications of diabetes:
  • stage 2+ diabetic retinopathy
  • renal impairment (with creatinine \>150micromol/l)
  • known history or symptoms of cardiovascular disease
  • foot ulceration
  • peripheral vascular disease
  • Known pregnancy or breastfeeding
  • Untreated or unstable respiratory disease
  • Known hypoglycaemia unawareness
  • Treatment with drugs known to interfere with glucose metabolism
  • For participants without Type 1 Diabetes Mellitus
  • Known pregnancy or breastfeeding
  • Untreated or unstable respiratory disease
  • Diagnosis of impaired fasting glucose, impaired glucose tolerance or diabetes mellitus
  • Treatment with drugs known to interfere with glucose metabolism

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2011

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT01401127

Start Date

January 1 2011

End Date

August 1 2011

Last Update

November 8 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wycombe Hospital

High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT